Hansa Biopharma AB (publ) (LON:0RC7)
London flag London · Delayed Price · Currency is GBP · Price in SEK
25.98
-0.14 (-0.54%)
At close: Jul 15, 2025

Hansa Biopharma AB Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
171192107206323953
Upgrade
Market Cap Growth
1.54%78.87%-47.81%-36.28%-66.17%251.50%
Upgrade
Enterprise Value
231221109172242822
Upgrade
Last Close Price
2.022.822.093.917.2421.48
Upgrade
PS Ratio
12.2415.5210.2516.70116.571753.27
Upgrade
PB Ratio
-3.56-4.51-8.184.285.218.61
Upgrade
P/TBV Ratio
---4.475.428.83
Upgrade
EV/Sales Ratio
16.4117.8910.4113.9687.451512.21
Upgrade
Debt / Equity Ratio
-1.63-1.83-5.161.310.050.00
Upgrade
Asset Turnover
0.240.190.100.110.030.01
Upgrade
Inventory Turnover
42.0140.5350.8063.3490.74-
Upgrade
Quick Ratio
1.822.222.575.915.3312.13
Upgrade
Current Ratio
1.832.292.666.065.5012.20
Upgrade
Return on Equity (ROE)
---382.37%-89.84%-54.84%-46.63%
Upgrade
Return on Assets (ROA)
-46.04%-43.41%-36.55%-26.67%-27.56%-25.32%
Upgrade
Return on Capital (ROIC)
-73.10%-66.46%-47.25%-32.93%-33.06%-29.20%
Upgrade
Earnings Yield
-28.15%-30.37%-60.53%-23.68%-13.88%-3.94%
Upgrade
FCF Yield
-28.71%-25.39%-55.02%-19.61%-12.25%-2.72%
Upgrade
Buyback Yield / Dilution
-26.66%-19.59%-16.95%-1.01%-5.45%-5.39%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.